Literature DB >> 21167385

Rare and unusual endocrine cancer syndromes with mutated genes.

Maya B Lodish1, Constantine A Stratakis.   

Abstract

The study of a number of rare familial syndromes associated with endocrine tumor development has led to the identification of genes involved in the development of these tumors. Major advances have expanded our understanding of the pathophysiology of these rare endocrine tumors, resulting in the elucidation of causative genes in rare familial diseases and a better understanding of the signaling pathways implicated in endocrine cancers. Recognition of the familial syndrome associated with a particular patient's endocrine tumor has important implications in terms of prognosis, screening of family members, and screening for associated conditions. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21167385      PMCID: PMC3053053          DOI: 10.1053/j.seminoncol.2010.10.019

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  120 in total

Review 1.  The essential role of RI alpha in the maintenance of regulated PKA activity.

Authors:  Paul S Amieux; G Stanley McKnight
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

2.  The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho.

Authors:  R F Lamb; C Roy; T J Diefenbach; H V Vinters; M W Johnson; D G Jay; A Hall
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

3.  Endocrine pancreatic islet disease with diarrhea. Report of a case due to diffuse hyperplasia of nonbeta islet tissue with a review of 54 additional cases.

Authors:  J V Verner; A B Morrison
Journal:  Arch Intern Med       Date:  1974-03

4.  The NF1 tumor suppressor critically regulates TSC2 and mTOR.

Authors:  Cory M Johannessen; Elizabeth E Reczek; Marianne F James; Hilde Brems; Eric Legius; Karen Cichowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

5.  An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors.

Authors:  A C Latronico; E M Pinto; S Domenice; M C Fragoso; R M Martin; M C Zerbini; A M Lucon; B B Mendonca
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

6.  Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity.

Authors:  J A Carney; L S Hruska; G D Beauchamp; H Gordon
Journal:  Mayo Clin Proc       Date:  1986-03       Impact factor: 7.616

7.  Identification and characterization of the tuberous sclerosis gene on chromosome 16.

Authors: 
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

8.  Pancreatic somatostatinoma. Clinical features and physiological implications.

Authors:  L I Larsson; M A Hirsch; J J Holst; S Ingemansson; C Kühl; S L Jensen; G Lundqvist; J F Rehfeld; T W Schwartz
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

9.  A prospective study of neurofibromatosis type 1 cancer incidence in the UK.

Authors:  L Walker; D Thompson; D Easton; B Ponder; M Ponder; I Frayling; D Baralle
Journal:  Br J Cancer       Date:  2006-06-20       Impact factor: 7.640

Review 10.  Extra-intestinal manifestations of familial adenomatous polyposis.

Authors:  Emma J Groen; Annemieke Roos; Friso L Muntinghe; Roelien H Enting; Jakob de Vries; Jan H Kleibeuker; Max J H Witjes; Thera P Links; André P van Beek
Journal:  Ann Surg Oncol       Date:  2008-07-09       Impact factor: 5.344

View more
  2 in total

1.  Sudden Death in a Patient with Carney's Complex.

Authors:  James Adam Rothschild; Melissa Kreso; Martin Slodzinski
Journal:  Anesth Pain Med       Date:  2013-03-26

Review 2.  Two Subsequent Metachroneus Solid Tumors: Oncocytic Variant Adrenocortical Carcinoma and Rhabdomyosarcoma of Childhood: Case Report and Literature Review

Authors:  Onur Akın; Erman Ataş; İrem Ayşe Atasoy; Nihal Durmaz; Ömer Kartal
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.